David L. Gillespie

1.5k total citations
28 papers, 1.2k citations indexed

About

David L. Gillespie is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, David L. Gillespie has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 11 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in David L. Gillespie's work include Cancer, Hypoxia, and Metabolism (12 papers), Glioma Diagnosis and Treatment (10 papers) and Meningioma and schwannoma management (4 papers). David L. Gillespie is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Glioma Diagnosis and Treatment (10 papers) and Meningioma and schwannoma management (4 papers). David L. Gillespie collaborates with scholars based in United States, South Korea and Italy. David L. Gillespie's co-authors include Randy L. Jensen, Brian T. Ragel, Kum Whang, William T. Couldwell, Xu-Li Wang, Zheng‐Rong Lu, Karen L. Salzman, Anita Y. Kinney, David A. Kelly and Rongzuo Xu and has published in prestigious journals such as PLoS ONE, Biomaterials and Analytical Chemistry.

In The Last Decade

David L. Gillespie

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Gillespie United States	19	586	417	368	177	136	28	1.2k
Kelly Burrell Canada	18	803 1.4×	254 0.6×	398 1.1×	137 0.8×	191 1.4×	26	1.5k
Elizabeth Cohen‐Jonathan‐Moyal France	14	519 0.9×	337 0.8×	558 1.5×	127 0.7×	217 1.6×	25	1.2k
Fumiharu Ohka Japan	23	1.0k 1.8×	678 1.6×	525 1.4×	188 1.1×	309 2.3×	99	1.8k
Bakhtiar Yamini United States	20	487 0.8×	317 0.8×	269 0.7×	85 0.5×	158 1.2×	44	1.0k
J.-C. Tonn Germany	15	541 0.9×	231 0.6×	724 2.0×	194 1.1×	196 1.4×	23	1.4k
Rolf Warta Germany	21	532 0.9×	324 0.8×	347 0.9×	105 0.6×	335 2.5×	53	1.2k
Andrew J. Tsung United States	25	706 1.2×	495 1.2×	366 1.0×	102 0.6×	352 2.6×	54	1.5k
Satoru Osuka Japan	21	677 1.2×	314 0.8×	390 1.1×	75 0.4×	355 2.6×	42	1.3k
Mirjam Hermisson Germany	14	614 1.0×	232 0.6×	504 1.4×	78 0.4×	229 1.7×	17	1.1k
Ryusuke Hatae Japan	17	295 0.5×	227 0.5×	554 1.5×	120 0.7×	216 1.6×	56	979

Countries citing papers authored by David L. Gillespie

Since Specialization

Citations

This map shows the geographic impact of David L. Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Gillespie more than expected).

Fields of papers citing papers by David L. Gillespie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Gillespie. The network helps show where David L. Gillespie may publish in the future.

Co-authorship network of co-authors of David L. Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Gillespie. A scholar is included among the top collaborators of David L. Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Gillespie. David L. Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xia, Wenxi, Neetu Singh, David L. Gillespie, et al.. (2025). Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy. Science Advances. 11(21). eadv2930–eadv2930.

Gillespie, David L., et al.. (2020). Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential. Journal of Neuro-Oncology. 146(3). 427–437. 16 indexed citations

Choi, Hyunsung, David L. Gillespie, Christopher Rice, et al.. (2015). Intermittent Induction of HIF-1α Produces Lasting Effects on Malignant Progression Independent of Its Continued Expression. PLoS ONE. 10(4). e0125125–e0125125. 15 indexed citations

Karsy, Michael, Nguyen Hoang, Lindsay Burt, et al.. (2015). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World Neurosurgery. 86. 210–219. 30 indexed citations

Gillespie, David L., et al.. (2014). Hypoxia-inducible factor–1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurgical FOCUS. 37(6). E8–E8. 41 indexed citations

Doyle, Adam J., Eileen M. Redmond, David L. Gillespie, et al.. (2014). Differential expression of Hedgehog/Notch and transforming growth factor-β in human abdominal aortic aneurysms. Journal of Vascular Surgery. 62(2). 464–470. 35 indexed citations

Towner, Rheal A., David L. Gillespie, A Schwager, et al.. (2013). Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neuro-Oncology. 15(3). 330–340. 36 indexed citations

Jensen, Randy L., Michael L. Mumert, David L. Gillespie, et al.. (2013). Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro-Oncology. 16(2). 280–291. 97 indexed citations

Towner, Rheal A., Randy L. Jensen, Howard Colman, et al.. (2012). ELTD1, a Potential New Biomarker for Gliomas. Neurosurgery. 72(1). 77–91. 63 indexed citations

10.

Liu, James K., Smruti Patel, David L. Gillespie, Kum Whang, & William T. Couldwell. (2011). R-flurbiprofen, a novel nonsteroidal anti-inflammatory drug, decreases cell proliferation and induces apoptosis in pituitary adenoma cells in vitro. Journal of Neuro-Oncology. 106(3). 561–569. 16 indexed citations

11.

Wang, Xu-Li, Rongzuo Xu, Xueming Wu, et al.. (2009). Targeted Systemic Delivery of a Therapeutic siRNA with a Multifunctional Carrier Controls Tumor Proliferation in Mice. Molecular Pharmaceutics. 6(3). 738–746. 112 indexed citations

12.

Gillespie, David L., Gregory J. Stoddard, Grant Ellsworth, et al.. (2008). Hypoxia‐regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer. 113(5). 1032–1042. 108 indexed citations

13.

Gillespie, David L., et al.. (2008). Silencing of HIF-1α by RNA Interference in Human Glioma Cells In Vitro and In Vivo. Methods in molecular biology. 487. 1–19. 12 indexed citations

14.

Gillespie, David L., et al.. (2007). Silencing of Hypoxia Inducible Factor-1α by RNA Interference Attenuates Human Glioma Cell GrowthIn vivo. Clinical Cancer Research. 13(8). 2441–2448. 79 indexed citations

15.

Ragel, Brian T., William T. Couldwell, David L. Gillespie, & Randy L. Jensen. (2007). Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurgical Review. 30(3). 181–187. 44 indexed citations

16.

Ragel, Brian T., Randy L. Jensen, David L. Gillespie, Stephen M. Prescott, & William T. Couldwell. (2006). Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer. 109(3). 588–597. 49 indexed citations

17.

Ragel, Brian T., et al.. (2006). CALCIUM CHANNEL ANTAGONISTS AUGMENT HYDROXYUREA- AND RU486-INDUCED INHIBITION OF MENINGIOMA GROWTH IN VIVO AND IN VITRO. Neurosurgery. 59(5). 1109–1121. 31 indexed citations

18.

Jensen, Randy L., Brian T. Ragel, Kum Whang, & David L. Gillespie. (2006). Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. Journal of Neuro-Oncology. 78(3). 233–247. 130 indexed citations

19.

Ragel, Brian T., Randy L. Jensen, David L. Gillespie, Stephen M. Prescott, & William T. Couldwell. (2005). Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. Journal of neurosurgery. 103(3). 508–517. 29 indexed citations

20.

Jensen, Randy L., David L. Gillespie, P.A. House, Lester J. Layfield, & Clough Shelton. (2004). Endolymphatic sac tumors in patients with and without von Hippel—Lindau disease: the role of genetic mutation, von Hippel—Lindau protein, and hypoxia inducible factor-1α expression. Journal of neurosurgery. 100(3). 488–497. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact